Get started
Author

K.L. Winthrop

Observed names: K L Winthrop, K Winthrop, K. L. Winthrop, K. Winthrop, KL Winthrop, Kevin Winthrop
OpenAlex ID: A5050439846
Mycobacterial diseases and antitumour necrosis factor therapy in USA
2012 · KL Winthrop, R Baxter, et al. · Annals of the Rheumatic Diseases · 269
Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasis
2017 · K.A. Papp, H. Bachelez, et al. · British Journal of Dermatology · 52
C ryptococcus gattii infection in solid organ transplant recipients: description of O regon outbreak cases
2015 · G.N. Forrest, P. Bhalla, et al. · Transplant Infectious Disease · 40
Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF- inhibitor therapy
2013 · C. D. Varley, A. A. Deodhar, et al. · Rheumatology · 24
Fri0123 Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 8.4 Years: an Updated Integrated Safety Analysis
2020 · M.C. Genovese, J.S. Smolen, et al. · Annals of the Rheumatic Diseases · 12
OP0248 Serious infection and associated risk factors in patients with moderate to severe rheumatoid arthritis treated with baricitinib
2017 · KL Winthrop, MC Genovese, et al. · Annals of the Rheumatic Diseases · 6
Happy Buddha?
2012 · K. L. Winthrop, C. D. Varley, et al. · Clinical Infectious Diseases · 5
Characteristics of frequent exacerbators in the US Bronchiectasis and NTM Research Registry (BRR)
2022 · N Lapinel, R Choate, et al. · European Respiratory Journal · 2
Longitudinal Changes in Forced Expiratory Volume 1 (FEV1) According to Exacerbation Frequency in Patients From the US Bronchiectasis and NTM Research Registry (BRR)
2023 · N. Lapinel, T.R. Aksamit, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Pos0235 Integrated Safety Analysis Update for Filgotinib (fil) in Patients (pts) With Moderately to Severely Active Rheumatoid Arthritis (ra) Receiving Treatment Over a Median of 2.2 Years (y)
2022 · K. Winthrop, Y. Tanaka, et al. · Annals of the Rheumatic Diseases · 1
PDF
Rhesus Macaque Model of Pulmonary Aging and Non-tuberculous Mycobacterium Infection Reveals Age Related Mechanisms of Disease Severity
2022 · N. Rhoades, M.H. Davies, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Surgical Outcome of Resectional Thoracic Surgery for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease in 98 U.S. Patients
2020 · J.H. Ku, S.A.R. Siegel, et al. · American Journal of Respiratory and Critical Care Medicine · 1
FRI0098 Hepatic safety in patients with rheumatoid arthritis who received isoniazid for latent tuberculosis: post-hoc analysis from phase 3 baricitinib studies
2018 · T.-Y. Hsieh, W.-N. Huang, et al. · Annals of the Rheumatic Diseases · 1
PDF
B107-05 Non-CF Bronchiectasis Occurrence, Exacerbation Rates, and Inhaled Antibiotic Use in the U.S.: A Population-based Descriptive Analysis
2026 · C N Cristancho Rojas, E Henkle, et al. · American Journal of Respiratory and Critical Care Medicine
B45-11 Baseline Fatigue and Associations With Dyspnea, Exacerbations, and Hospitalizations in Patients With Bronchiectasis
2026 · A M Yohannes, A E Brunton, et al. · American Journal of Respiratory and Critical Care Medicine
B69-19 Evaluating the Role of Clofazimine in Pulmonary NTM Disease: A Retrospective Analysis of Clinical Outcomes and Adverse Effects in the US Bronchiectasis and NTM Research Registry
2026 · D Munce, W Elmaraachli, et al. · American Journal of Respiratory and Critical Care Medicine
B107-10 Burkholderia, Achromobacter and Stenotrophomonas in Non-Cystic Fibrosis Bronchiectasis: Demographic and Clinical Characteristics From the US Bronchiectasis and Nontuberculous Mycobacterium Research Registry
2026 · C Swenson, D Fraulino, et al. · American Journal of Respiratory and Critical Care Medicine
B107-04 Computed Tomography Findings and Clinical Outcomes in Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD): A Systematic Review
2026 · C N Cristancho Rojas, E Henkle, et al. · American Journal of Respiratory and Critical Care Medicine
Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?
2026 · James D. Chalmers, Charles S. Haworth, et al. · European Respiratory Journal
Impact de la décroissance des corticoïdes dans l’artérite à cellules géantes : analyse de l’essai SELECT-GCA
2025 · F. Buttgereit, K.L. Winthrop, et al. · La Revue de Médecine Interne
Association of Otitis and/or Rhinosinusitis and Pseudomonas Aeruginosa in Sputum of Patients With Non-cystic Fibrosis Bronchiectasis
2025 · T. Grabauskas, A. Brunton, et al. · American Journal of Respiratory and Critical Care Medicine
Baseline Dyspnea Associated With Risk for Severe Features of Bronchiectasis Phenotype in the US Bronchiectasis and Nontuberculous Mycobacterium Research Registry
2025 · A.M. Yohannes, A. Brunton, et al. · American Journal of Respiratory and Critical Care Medicine
The MAC2v3 Randomized Pragmatic Clinical Trial of Macrolide-based 2- Versus 3-drug Treatment for Mycobacterium Avium Complex Pulmonary Disease: Baseline Participant Characteristics
2025 · E. Henkle, D.J. Addrizzo-Harris, et al. · American Journal of Respiratory and Critical Care Medicine
Clinical Features of Bronchiectasis Patients With Rheumatoid Arthritis: An Analysis of the Bronchiectasis Research Registry
2023 · L. Sullivan, A.E. Brunton, et al. · American Journal of Respiratory and Critical Care Medicine
Cftr Mutation and Increased Rates of Pulmonary Infections Among Patients From the US Bronchiectasis and NTM Research Registry
2023 · C. Richards, A. Brunton, et al. · American Journal of Respiratory and Critical Care Medicine
Works count: 51
Citation count: 415
H-index: 6
I10-index: 5
Year
Topic
Type